Form D · Other
Molecular Science Corp
Toronto, A6 · CIK 0001731206
Offering snapshot reported Feb 22, 2018 · SEC filing
- Reported sold
- $18.1K Offering amount: $18.1K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 22, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2018 | Initial | $18,061 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-306252
Canadian dollars have been converted to US dollars based on the 0.8027 Bank of Canada exchange rate in effect on 1-22-18.
Source: Form D, filed Feb 22, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard Goldman | Director |
| Sameet Kanade | Director, Executive |
| Ian Morton | Director |
| Scott Walters | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
55 St. Clair Avenue West, Suite 408
Toronto, A6, M4V 2Y7
Toronto, A6, M4V 2Y7